Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: cyclophosphamide|DRUG: methotrexate|DRUG: sunitinib malate|OTHER: laboratory biomarker analysis
Sponsor: University of California, San Francisco
Collaborators: National Cancer Institute (NCI)